Hypoxia-driven heterogeneous expression of α5 integrin in glioblastoma stem cells is linked to HIF-2α

Authors: Messé, Mélissa, Bernhard, Chloé, Foppolo, Sophie, Thomas, Lionel, Marchand, Patrice, Herold-Mende, Christel, Idbaih, Ahmed, Kessler, Horst, Etienne-Selloum, Nelly, Ochoa, Charles, Tambar, Uttam K., Elati, Mohamed, Laquerriere, Patrice, Entz-Werle, Natacha, Martin, Sophie, Reita, Damien, Dontenwill, Monique

Source: In BBA - Molecular Basis of Disease December 2024 1870(8)

Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer.

Authors: Chocry, Mathieu, Leloup, Ludovic, Parat, Fabrice, Messé, Mélissa, Pagano, Alessandra, Kovacic, Hervé

Source: Cancers; Dec2022, Vol. 14 Issue 23, p5894, 17p

Subject Terms: IN vitro studies, DRUG efficacy, IN vivo studies, CANCER chemotherapy, DEOXYCYTIDINE, APOPTOSIS, ANTINEOPLASTIC agents, COLORECTAL cancer, CANCER patients, TREATMENT effectiveness, ORGANOPLATINUM compounds, TREATMENT failure, CELLULAR signal transduction, CELL proliferation, TRANSFERASES, OXALIPLATIN, ALTERNATIVE medicine, MITOGEN-activated protein kinases, REACTIVE oxygen species, DRUG resistance in cancer cells, CYTOTOXINS